Lung Cancer clinical trials in Australia
126 lung cancer trials recruiting in Australia
Lung cancer is one of the most common cancers in Australia. Areas of active research include new immunotherapy combinations, targeted therapies for EGFR, ALK, KRAS, and other mutations, and novel treatment approaches for both non-small cell and small cell lung cancer.
Describe the diagnosis below and we'll find matching trials.
For information only. Matches are AI generated. Always consult your healthcare team prior to any medical decisions.
Three steps. About 30 seconds.
Describe
Tell us about your lung cancer in your own words, or use the step-by-step form. Even rough detail works.
Match
We search actively recruiting lung cancer trials in Australia and explain why each may be relevant to you.
Discuss
Get clear summaries of each trial and questions to ask your doctor. Print or save the results to take to your next appointment.
Lung Cancer clinical trials: common questions
The things people most often ask about lung cancer trials.
Lung cancer is divided into two main groups based on how the cells appear under a microscope. Non-small cell lung cancer (NSCLC) is the more common group and includes adenocarcinoma and squamous cell carcinoma. Small cell lung cancer (SCLC) is rarer, tends to grow and spread more quickly, and is biologically very different. The two are studied as separate diseases because they respond to different families of treatment.
The information above is general in nature. Always discuss specific trial options and treatment decisions with your oncologist or treating team.
Search other cancer types
TrialLight covers over 25 cancer types across Australia.